FPS
COLL icon

Fieldpoint Private Securities’s Collegium Pharmaceutical COLL Stock Holding History

Fieldpoint Private Securities’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-50
Closed -$1K – 1528
2022
Q1 		$1K Buy
+50
New +$945 ﹤0.01% 1551

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Fieldpoint Private Securities's COLL Position: Q2 2022 in Review

Fieldpoint Private Securities sold out of Collegium Pharmaceutical (COLL) in Q2 2022, closing a stake of 50 shares — an estimated $1K sold.

Fieldpoint Private Securities first reported a position in COLL in Q1 2022 and held it in 1 quarter. The position peaked at $1K in Q1 2022. 157 funds tracked by Wall St. Rank hold COLL as of Q2 2022.

  • Fieldpoint Private Securities reported no remaining Collegium Pharmaceutical position as of Q2 2022 after selling out during the quarter.
  • Fieldpoint Private Securities sold 50 Collegium Pharmaceutical shares in Q2 2022, an estimated $1K.
  • Fieldpoint Private Securities first reported a position in Collegium Pharmaceutical in Q1 2022 and held it in 1 quarter.
  • Fieldpoint Private Securities's Collegium Pharmaceutical position peaked at $1K in Q1 2022.
  • 157 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2022.

Based on Fieldpoint Private Securities's 13F filing for Q2 2022, filed 5 Aug 2022.